Short-term prognostic value of serum neuron specific enolase and S100B in acute stroke patients

被引：50

作者：

Gonzalez-Garcia, Sergio ^{[1
]}

Gonzalez-Quevedo, Alina ^{[1
]}

Fernandez-Concepcion, Otman ^{[1
]}

Pena-Sanchez, Marisol ^{[1
]}

Menendez-Sainz, Caridad ^{[1
]}

Hernandez-Diaz, Zenaida ^{[1
]}

Arteche-Prior, Marianela ^{[1
]}

Pando-Cabrera, Alejandro ^{[1
]}

Fernandez-Novales, Carlos ^{[2
]}

机构：

[1] Inst Neurol & Neurosurg, Havana, Cuba

[2] Univ Hosp Cdte Manuel Fajardo, Havana, Cuba

来源：

CLINICAL BIOCHEMISTRY | 2012年 / 45卷 / 16-17期

关键词：

Stroke; Ischemic stroke; Hemorrhagic stroke; S100B; Neuron specific enolase; Outcome; ACUTE ISCHEMIC-STROKE; BLOOD BIOMARKERS; S-100; PROTEIN; MARKERS; CLASSIFICATION; INFARCTION; DIAGNOSIS; SUBTYPES; DAMAGE;

D O I：

10.1016/j.clinbiochem.2012.07.094

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

Objective: To explore the value of blood markers for brain injury as outcome predictors in acute stroke. Design and methods: The study included 61 patients with acute stroke (44 ischemic and 17 hemorrhagic) and a high risk control group (79 individuals with no known history of neurological disease). Serum neuron specific enolase (NSE) and S100B were determined by immunoassay (CanAg Diagnostics, Sweden). Outcome at 60 days was evaluated with clinical scales. Results: Higher concentrations of NSE and S100B were measured in patients compared to high risk controls, but they were not related to stroke severity on admission. NSE was associated with functional neurological outcome at 60 days and to the degree of recovery, whereas S100B exhibited a strong correlation with depression symptoms at 60 days. Conclusions: The measurements of serum concentrations of NSE and S100B after acute stroke may be clinically relevant for predicting functional neurological outcome and post-stroke depression, respectively. (C) 2012 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

引用

页码：1302 / 1307

页数：6

共 30 条

[1] CLASSIFICATION OF SUBTYPE OF ACUTE ISCHEMIC STROKE - DEFINITIONS FOR USE IN A MULTICENTER CLINICAL-TRIAL [J].

ADAMS, HP ;

BENDIXEN, BH ;

KAPPELLE, LJ ;

BILLER, J ;

LOVE, BB ;

GORDON, DL ;

MARSH, EE ;

KASE, CS ;

WOLF, PA ;

BABIKIAN, VL ;

LICATAGEHR, EE ;

ALLEN, N ;

BRASS, LM ;

FAYAD, PB ;

PAVALKIS, FJ ;

WEINBERGER, JM ;

TUHRIM, S ;

RUDOLPH, SH ;

HOROWITZ, DR ;

BITTON, A ;

MOHR, JP ;

SACCO, RL ;

CLAVIJO, M ;

ROSENBAUM, DM ;

SPARR, SA ;

KATZ, P ;

KLONOWSKI, E ;

CULEBRAS, A ;

CAREY, G ;

MARTIR, NI ;

FICARRA, C ;

HOGAN, EL ;

CARTER, T ;

GURECKI, P ;

MUNTZ, BK ;

RAMIREZLASSEPAS, M ;

TULLOCH, JW ;

QUINONES, MR ;

MENDEZ, M ;

ZHANG, SM ;

ALA, T ;

JOHNSTON, KC ;

ANDERSON, DC ;

TARREL, RM ;

NANCE, MA ;

BUDLIE, SR ;

DIERICH, M ;

HELGASON, CM ;

HIER, DB ;

SHAPIRO, RA .

STROKE, 1993, 24 (01) :35-41

[2] Salivary neuron specific enolase: an indicator for neuronal damage in patients with ischemic stroke and stroke-prone patients [J].

Al-Rawi, Natheer H. ;

Atiyah, Karim M. .

CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2009, 47 (12) :1519-1524

[3] CLASSIFICATION AND NATURAL-HISTORY OF CLINICALLY IDENTIFIABLE SUBTYPES OF CEREBRAL INFARCTION [J].

BAMFORD, J ;

SANDERCOCK, P ;

DENNIS, M ;

BURN, J ;

WARLOW, C .

LANCET, 1991, 337 (8756) :1521-1526

[4] Reliability of S100B in predicting severity of central nervous system injury [J].

Bloomfield, Stephen M. ;

McKinney, James ;

Smith, Les ;

Brisman, Jonathan .

NEUROCRITICAL CARE, 2007, 6 (02) :121-138

[5] Temporal profile and clinical significance of serum neuron-specific enolase and S100 in ischemic and hemorrhagic stroke [J].

Brea, David ;

Sobrino, Tomas ;

Blanco, Miguel ;

Cristobo, Ivan ;

Rodriguez-Gonzalez, Raquel ;

Rodriguez-Yanez, Manuel ;

Moldes, Octavio ;

Agulla, Jesus ;

Leira, Rogelio ;

Castillo, Jose .

CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2009, 47 (12) :1513-1518

[6] MEASUREMENTS OF ACUTE CEREBRAL INFARCTION - A CLINICAL EXAMINATION SCALE [J].

BROTT, T ;

ADAMS, HP ;

OLINGER, CP ;

MARLER, JR ;

BARSAN, WG ;

BILLER, J ;

SPILKER, J ;

HOLLERAN, R ;

EBERLE, R ;

HERTZBERG, V ;

RORICK, M ;

MOOMAW, CJ ;

WALKER, M .

STROKE, 1989, 20 (07) :864-870

[7]

Buergo Zuaznabar MA, 2009, GUIAS PRACTICA CLIN

[8] SERUM NEURON SPECIFIC ENOLASE (NSE) LEVELS AS AN INDICATOR OF NEURONAL DAMAGE IN PATIENTS WITH CEREBRAL INFARCTION [J].

CUNNINGHAM, RT ;

YOUNG, IS ;

WINDER, J ;

OKANE, MJ ;

MCKINSTRY, S ;

JOHNSTON, CF ;

DOLAN, OM ;

HAWKINS, SA ;

BUCHANAN, KD .

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1991, 21 (05) :497-500

[9] Criteria for a Clinically Informative Serum Biomarker in Acute Ischaemic Stroke: A Review of S100B [J].

Dassan, Pooja ;

Keir, Geoffrey ;

Brown, Martin M. .

CEREBROVASCULAR DISEASES, 2009, 27 (03) :295-302

[10] Serum S100B: A Potential Biomarker for Suicidality in Adolescents? [J].

Falcone, Tatiana ;

Fazio, Vincent ;

Lee, Catherine ;

Simon, Barry ;

Franco, Kathleen ;

Marchi, Nicola ;

Janigro, Damir .

PLOS ONE, 2010, 5 (06)

← 1 2 3 →